For US Healthcare Professionals Only

For questions about coronavirus/COVID-19 and using NIOX VERO®, please visit the NIOX VERO Coronavirus/COVID-19 FAQ.

FeNO Recognition

FeNO-Guided Management is Recognized by the Following:

Professional Associations

ATS: American Thoracic Society3

AAAAI: American Academy of Allergy Asthma & Immunology4 -

ACAAI: American College of Allergy, Asthma & Immunology4 -

BTS: British Thoracic Society5

GINA: Global Initiative for Asthma6

SIGN: Scottish Intercollegiate Guidelines Network5

Governmental Agencies

AHRQ: Agency for Healthcare Research and Quality7 -

NICE: National Institute for Clinical Excellence8

Patient Advocacy Groups

AAFA: Asthma and Allergy Foundation of America9 -

Allergy & Asthma Network9


References: 1. LaForce C, Brooks E, Herje N, Dorinsky P, Rickard K. Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. Ann Allergy Asthma Immunol. 2014;113(6):619-623. 2. Hanania NA, Alpan, O, Hamilos, DL et al. Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy. Ann Intern Med. 2011;154:573-582. 3. Dweik RA, Boggs PB, Erzurum SC, et al; on behalf of the American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. 4. American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology. AAAAI/ACAAI joint statement of support of the ATS clinical practice guideline: interpretation of exhaled nitric oxide for clinical applications. Accessed March 31, 2016. 5. British Thoracic Society. British guideline on the management of asthma: A national clinical guideline, 2016. Available at: 6. Global Initiative for Asthma. Difficult-To-Treat & Severe Asthma in adolescent and adult patients: A GINA Pocket Guide For Health Professionals. Accessed November 20, 2018. 7.Agency for Healthcare Research and Quality (ARHQ). The clinical utility of fractional exhaled nitric oxide (FeNO) in asthma management. Accessed February 26, 2018. 8. NICE guideline [NG80]: Asthma: diagnosis, monitoring and chronic asthma management. Published November 2017: 9. Data on file. Circassia Pharmaceuticals January 2019.